Chromoblastomycosis – A clinical and mycological study of 71 cases from Sri Lanka

@article{Attapattu2004ChromoblastomycosisA,
  title={Chromoblastomycosis – A clinical and mycological study of 71 cases from Sri Lanka},
  author={M C Attapattu},
  journal={Mycopathologia},
  year={2004},
  volume={137},
  pages={145-151}
}
Chromoblastomycosis, a well-documented chronic fungal infection, represents a specific clinical entity with typical warty cutaneous nodules and a worldwide distribution. Although more prevalent in tropical and subtropical regions, only a few reports are available from Sri Lanka or from Asia. Five etiologic agents of chromoblastomycosis have been recognized worldwide. Of these the majority of infections have been caused by Fonsecaea pedrosoi. During the period from 1952 to 1962, only twelve… 
Chromoblastomycosis: an overview of clinical manifestations, diagnosis and treatment.
TLDR
There is no treatment of choice for this neglected mycosis, but rather several treatment options, and treatment should be guided according to clinical, mycological and histopathological criteria.
Chromoblastomycosis in Taiwan: A report of 30 cases and a review of the literature
TLDR
Surgical excision achieved a higher complete remission rate than the other forms of treatment did, and the lesions presented as papuloplaque, verrucous, cicatricial, targetoid, or mixed types.
Endemic Chromoblastomycosis Caused Predominantly by Fonsecaea nubica, Madagascar
TLDR
Patients in Madagascar who had chronic subcutaneous lesions suggestive of dermatomycosis during March 2013-June 2017 were recruited and molecular analysis identified the Fonsecaea sp.
Chromoblastomycosis in Kerala, India.
TLDR
Chromoblastomycosis is very common in Central Kerala mainly affects male agriculturists especially those employed in rubber plantations and the most common organism is F. pedrosoi.
A STUDY ON CHROMOBLASTOMYCOSIS IN A TERTIARY CARE HOSPITAL (DMCH), LAHERIASARAI, BIHAR
TLDR
This report is a retrospective hospital record-based analysis of all cases of chromoblastomycosis who presented to the dermatology outpatient department of the tertiary care hospital during the past 3 years, finding that the disease was seen predominantly in middle-aged male.
Case Report: A Case of Chromoblastomycosis Caused by Fonsecaea pedrosoi in Vietnam
TLDR
This is the first case of chromoblastomycosis caused by Fonsecaea pedrosoi reported in Vietnam, and after 1-month treatment with itraconazole, the lesion has significant improvement.
Chromoblastomycosis: a retrospective study of 325 cases on Amazonic Region (Brazil)
TLDR
A retrospective study of 325 cases of chromoblastomycosis diagnosed in the last 55 years in the Amazon region showed that the main age group affected by the diseases range from 41 to 70 years-old.
Cutaneous localized annular chromoblastomycosis
TLDR
A new clinical type of CBM is described, and itraconazole appears to be effective and safe in curing these patients after no more than 9 months of therapy.
Chromoblastomycosis
TLDR
In its more severe clinical forms, CBM may cause an incapacity for labor due to fibrotic sequelae and also due to a series of clinical complications, and if not recognized at an early stage, this disease can be refractory to antifungal therapy.
CHROMOBLASTOMYCOSIS: A NEGLECTED TROPICAL DISEASE
TLDR
The most used therapeutic options against Chromoblastomycosis are reviewed as well as the several factors that may have impact on the patient's outcome.
...
...

References

SHOWING 1-10 OF 18 REFERENCES
Chromomycosis: a review
  • D. Vollum
  • Medicine
    The British journal of dermatology
  • 1977
TLDR
Chromomycosis or verrucose dermatitis is the classic form of the disease: A chronic granulomatous infection characterized by warty nodules and plaques which may ulcerate and in male agricultural workers, who are nearly always in the 30-50 age group.
Chromoblastomycosis and phaeohyphomycosis: new concepts, diagnosis, and mycology.
  • M. Mcginnis
  • Medicine
    Journal of the American Academy of Dermatology
  • 1983
Chromomycosis: a clinical and mycologic study of thirty-five cases observed in the hinterland of Rio Grande do Sul, Brazil.
TLDR
Data on thirty-five patients with chromomycosis seen in the hinterland of the State of Rio Grande do Sul (Brazil) are reviewed, and an account is given of its regional distribution.
Chromomycosis: a clinical and mycologic study of thirty-five cases observed in the hinterland of Rio Grande do Sul, Brazil.
TLDR
Data on thirty-five patients with chromomycosis seen in the hinterland of the State of Rio Grande do Sul (Brazil) are reviewed and an account is given of its regional distribution.
Chromoblastomycosis in Malaysia
TLDR
Nine cases of histologically diagnosed Chromoblastomycosis are reported from Malaysia and the diagnosis was established by finding characteristic brown muriform cells in the tissue sections.
Phylogenetic relationships of human-pathogenic Cladosporium (Xylohypha) species inferred from partial LS rRNA sequences.
TLDR
Human-pathogenic and saprophytic Cladosporium species were found to be phylogenetically distinct from each other and were considered to be anamorphs of Herpotrichiellaceae and Mycosphaerellaceae, respectively, and should be classified in different anamorph-genera.
Nutritional physiology and taxonomy of human-pathogenic Cladosporium-Xylohypha species.
TLDR
Physiological profiles of type, authentic and some additional isolates of Cladosporium-Xylohypha species of purported herpotrichiellaceous relationship are established and a diagnostic key for the recognized Cladophialophora species and to morphologically similar taxa is provided.
Chromoblastomycosis. Report of a case from Tripoli, Libya.
A case of chromoblastomycosis which showed typical clinical and pathological features is presented from Tripoli, Libya, for record, as no cases seem to have been reported from that region.
Chromoblastomycosis in India
TLDR
An additional 30 infected Indian patients are reviewed and four patients with chromoblastomycosis are presented, resulting in a total of 30 infected patients being reviewed.
...
...